ArticleGastro hep advances2026

Chemokine Ligand-3 (CCL3) as a Novel Mediator of Inflammatory Bowel Disease Activity.

Eileen O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.